• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Small Innovators & Niche CROs

    Focus on Science

    Rapid and Data Rich Chromatographic Method Development

    Preparing Your Post Pandemic Talent Strategy

    How Modern Near-Infrared Came to Be
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Bristol Myers Squibb Expands at Cambridge Crossing

    Amgen Completes Five Prime Acquisition

    Sartorius Expands in the UK

    Obituary Notice: Russell “Russ” Haines

    Abenza Chooses North Carolina for New Biologics Manufacturing Site
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Abenza Chooses North Carolina for New Biologics Manufacturing Site

    Catalent Adds Cryogenic Capabilities at Philadelphia Facility

    Recro, Ensysce Expand Development and Manufacturing Partnership

    Metrics Names Stephanie Emory Associate Director of Pharma Development

    Albumedix Completes Commercial-Scale Mfg. Facility Expansion
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Obituary Notice: Russell “Russ” Haines

    Catalent Adds Cryogenic Capabilities at Philadelphia Facility

    Cryoport Acquires Critical Transport Solutions Australia

    PharmParts – This Makes Sense!

    Securing Your API Supply Chain: Three Keys to Success
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Bristol Myers Squibb Expands at Cambridge Crossing

    Amgen Completes Five Prime Acquisition

    Sartorius Expands in the UK

    Abenza Chooses North Carolina for New Biologics Manufacturing Site

    Arkema Recruits Dotmatics as its R&D Digitalization Partner
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Ensuring Pharma Manufacturing Quality

    What Will Change at FDA for 2021?

    RBQM Comes of Age: COVID as a Catalyst for Change

    Post-Pandemic Regulations

    Enteris BioPharma: Custom Solutions – From Bench to Market
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Baxter BioPharma Solutions

    Reed-Lane

    PCI Pharma Services

    Quotient Sciences

    Emergent BioSolutions
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Aphena Pharma Solutions

    Almac Group

    Alcami

    Emergent BioSolutions

    PCI Pharma Services
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Managing Your Career

    Do What You Love

    Classical “bad” wisdom that could kill your career aspiration

    Do What You Love
    Related CONTENT
    • Softweb Solutions
    • FUJIFILM Irvine Scientific Launches BalanCD Gal Supplement
    • Nephron, Clemson Collaborate on Syringe-Filling Automation
    • Sartorius Launches New Services for Mammalian Cell Bank Manufacture
    • Inovalon Implements Platform Initiative for AstraZeneca
    David G. Jensen, Contributing Editor09.16.19
    “Do what you love and the money will follow.”

    How many times have good-natured and helpful people provided this sage bit of advice to those in the job market? Tens of millions. It’s one of the most common pieces of job search commentary, and we’ve all heard it before. Perhaps it was when you were getting out of school, and a relative or Pastor wanted to give you a bit of inspiration. You know, to help you get over your worries about a life filled with monetary obligations. Perhaps like me, it came to you at a time when you were unemployed, bouncing about and trying to figure out what would come next.

    Yes, it would be great to be able to do what you love and not have to worry about making a living. To be able let a “good living” come to you, now that is something to aspire to, for sure. The problem is that in reality it doesn’t work this way. For me, there’s nothing I would love more than to write on a full-time basis. Maybe for you it is to pick up a guitar and become a songwriter. For someone else, it may be going to Africa and fighting Ebola. While I would cheer any of those ideas, I think it is much more difficult to pull this off than this simple bit of “wisdom” implies. Yes, you could sacrifice everything and take on one of these ideas, but most of us wouldn’t last long using that approach.

    I spoke recently to two people who really love what they do, and I wanted to know more about how they happened to find themselves in that enviable position. Let me preface by saying that I am one of those who loves his work; my thought is that it isn’t by targeting your hobby that you find your passion and a good life to go with it. Instead, it seems to happen by digging into a job, even one that may not seem like what you love, at least initially. It is surprising how often that job later proves to have given you the keys to your dream of job satisfaction!

    “I went through my PhD program because I wanted to cure cancer. Someone very close to me in my younger life had passed on due to that terrible disease, and my desire to drive that cancer off the face of the planet drove me to get my education as a cell biologist,” Nancy told me. She’s a director of cell culture process development for one of my client companies. When I heard how passionate she was about her original goal, I asked her if she had been terribly disappointed to have moved quite far from her original goal of discovery science.

    “It was disappointing to find that my skills were more useful in other areas, and in particular, to go to work for a company that had no commercial interests in cancer research. My first job came from a company pursuing a cure for an STD. But what happened was that I found something I love anyway, even in that environment. A year into my job, I moved into the pilot plant to help develop an assay that was critical to scale-up, and then I added leadership experience in something that I found interesting. There’s a certain magic to cells in culture in a bioprocess, and I didn’t realize this early, but being in the industry it began to fascinate me. My career began to revolve more and more around an area of expertise that I developed because of that newfound love for making cells happy in bioreactors.”

    Nancy’s career blossomed naturally into a new area and she initially just went along for the ride. But it’s also possible that you could find yourself suddenly thrust into a change—a dramatic one, perhaps. That doesn’t necessarily need to be a bad thing. Take the case of Ray, a very successful director of business development for one of the leading microbials companies selling biostimulants to farmers and large growers:
    “I had gone back to graduate school after enjoying my initial work in microbiology. Initially, I thought I’d end up with a PhD, but I had a real conflict with my Professor. Graduate training wasn’t what I thought it was going to be, and I left the program with a Masters degree,” Ray told me as he described his transition into a business career. “I was really broken up, because I loved the science so much, and while I knew that I could work in science with a Masters, I found after a time in my first job that I would never be calling the shots without the PhD.”

    Ray found himself suddenly in the job market after a company reorganization, and it was then that he decided to skip out on his initial passion for bench science. Yes, it was what he loved, but he became a realist in the hard months of looking for another position.

    “I became much more flexible after looking for a few months. An opportunity came about through a networking contact of mine to talk to the director of sales for a major reagent supplier about a position supporting the sales force. It was called “Applications Support” and it got me back my employed status.

    “Something happened, and rather quickly,” Ray reported. “I started working with the company’s customers, solving their issues with our product, and I realized how much I enjoyed helping others with their research. In fact, I was better at that than I was while doing my own science. Within six months, I had moved into the sales force, and then later into business development, which was essentially my employer’s business-to-business arm, where we use our technologies to build joint ventures or new concepts with other suppliers. I love what I do. I still get the same thrill out of this work as I did when I worked with my first customer twelve years ago.”

    Based on the informal study I’ve made of job satisfaction over the years, I believe that this job advice about doing what you love can be restated into a new version of that sage career wisdom: “Go to work, find something you like and become great at it. The money will follow.” You can find what you love in your job. You don’t have to drop out and move to Alaska to become a fishing guide.

    Take what you enjoy the most in your present job and explore how you can get even better at it. Focus on making this special area more and more what you do. Believe me, the money will follow. As a headhunter working for companies all over the world who are looking to hire specialists in some area of expertise or another, I can tell you that every employer wants to find someone like Nancy or Ray—a new hire full of passion and enthusiasm for their subject matter. People who carry this love of their career choice with them will always be in demand.


    David G. Jensen
    Contributing Editor

    Dave Jensen is CEO and Founder of CTI Executive Search. He can be reached at (928) 274-2266 or via davejensen@careertrax.com; www.careertrax.com.
    Related Searches
    • training
    • Development
    • Process Development
    • study
    Suggested For You
    Softweb Solutions Softweb Solutions
    FUJIFILM Irvine Scientific Launches BalanCD Gal Supplement FUJIFILM Irvine Scientific Launches BalanCD Gal Supplement
    Nephron, Clemson Collaborate on Syringe-Filling Automation Nephron, Clemson Collaborate on Syringe-Filling Automation
    Sartorius Launches New Services for Mammalian Cell Bank Manufacture Sartorius Launches New Services for Mammalian Cell Bank Manufacture
    Inovalon Implements Platform Initiative for AstraZeneca Inovalon Implements Platform Initiative for AstraZeneca
    Syapse, Pfizer in Oncology Precision Medicine Pact Syapse, Pfizer in Oncology Precision Medicine Pact
    Molding a True Sense of Purpose at Work Molding a True Sense of Purpose at Work
    Lilly Lilly's CYRAMZA Gains Fifth Indication
    Provectus Appoints COO  Provectus Appoints COO
    Sartorius Launches New Cell Culture Microbioreactor System Sartorius Launches New Cell Culture Microbioreactor System
    CENTOGENE Appoints AI Director CENTOGENE Appoints AI Director
    Three Key Challenges for Wide-Scale AI Adoption in Pharma Three Key Challenges for Wide-Scale AI Adoption in Pharma
    GSK, AstraZeneca, CPI to Build Continuous Mfg. Facility GSK, AstraZeneca, CPI to Build Continuous Mfg. Facility
    Career Inflection Points Career Inflection Points

    Related Managing Your Career

    • Professional Etiquette at Two Critical Moments

      Professional Etiquette at Two Critical Moments

      Starting, or leaving, a job presents unique challenges.
      David G. Jensen, Contributing Editor 04.01.21

    • Stopping Career Burnout in Its Tracks

      Stopping Career Burnout in Its Tracks

      How to recognize and successfully combat—even avoid—burnout before it takes its toll.
      Ryan Raver, PhD, Contributing Editor 03.01.21

    • The Art and Science of Recruitment

      The Art and Science of Recruitment

      Chapter Four: Interview day and the importance of the hiring manager.
      David G. Jensen, Contributing Editor 01.27.21


    • The Art and Science of Recruitment

      The Art and Science of Recruitment

      Chapter Three: Landing the Best Candidate.
      David G. Jensen, Contributing Editor 11.17.20

    • The Art and Science of Recruitment

      The Art and Science of Recruitment

      Chapter Two: Building Word-of-Mouth Via Networking.
      David G. Jensen, Contributing Editor 10.14.20

    • The Art and Science of Recruitment

      The Art and Science of Recruitment

      Chapter One: Define your need. Craft your message.
      David G. Jensen, Contributing Editor 09.09.20


    • Building Dynamic Levels of Influence

      Building Dynamic Levels of Influence

      What makes a true leader in today’s modern workplace?
      Ryan Raver, PhD, Contributing Editor 05.05.20

    • Fully Developing Your Executive Presence

      Fully Developing Your Executive Presence

      Do you have the “It” factor?
      Ryan Raver, PhD , Contributing Editor 03.04.20

    • HR Trends Affect the Fast Track Science Career

      HR Trends Affect the Fast Track Science Career

      In many ways HR are the gatekeepers of our upward momentum.
      David G. Jensen, Contributing Editor 11.20.19


    • Escaping the Niche Career Box

      Escaping the Niche Career Box

      Broaden your horizons to unlock your true growth potential.
      Ryan Raver, PhD, Contributing Editor 10.15.19

    • Molding a True Sense of Purpose at Work

      Molding a True Sense of Purpose at Work

      Defining what it means to move from job, to career, to calling
      Ryan Raver, PhD, Contributing Editor 07.15.19

    • The Headhunter’s Call

      The Headhunter’s Call

      Suggestions for optimizing the potential of a new relationship
      Dave Jensen, Contributing Editor 06.13.19


    • Get up to Speed Fast in Your New Job

      Get up to Speed Fast in Your New Job

      Some practical advice on how to adjust to your new work environment from day one.
      Ryan Raver, PhD, Contributing Editor 05.07.19

    • Career Inflection Points

      Career Inflection Points

      With dramatic change come new opportunities
      David G. Jensen, Contributing Editor 04.05.19

    • Take Charge of Your Career Growth

      Take Charge of Your Career Growth

      Career advancement and enhancing workplace satisfaction is all about creating opportunities
      Ryan Raver, PhD, Contributing Editor 03.06.19

    Trending
    • Thermo Fisher Acquires PPD For $17.4B
    • Ensuring Pharma Manufacturing Quality
    • Bristol Myers Squibb Expands At Cambridge Crossing
    • Abenza Chooses North Carolina For New Biologics Manufacturing Site
    • Amgen Completes Five Prime Acquisition
    Breaking News
    • Bristol Myers Squibb Expands at Cambridge Crossing
    • Amgen Completes Five Prime Acquisition
    • Sartorius Expands in the UK
    • Obituary Notice: Russell “Russ” Haines
    • Abenza Chooses North Carolina for New Biologics Manufacturing Site
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Small Innovators & Niche CROs
    • Focus on Science
    • Rapid and Data Rich Chromatographic Method Development
    • Preparing Your Post Pandemic Talent Strategy
    • How Modern Near-Infrared Came to Be
    • Securing Your API Supply Chain: Three Keys to Success
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    AstaReal Astaxanthin Ingredient Receives U.S. Patent Approval
    Study on Kemin’s DailyZz Botanical Blend Uncovers Sleep Quality, Next-Day Performance Benefits
    FDA’s Dr. Cara Welch Opening Speaker at the 9th AHPA Botanical Congress
    Coatings World

    Latest Breaking News From Coatings World

    Jebsen & Jessen, Innospec Sign Distribution Agreement
    IGL Coatings Announces Partnership in Finland
    Axalta Schedules 1Q 2021 Earnings Conference Call
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Iterative Scopes Announces IBD-Focused Scientific Advisory Board
    Vicarious Surgical, D8 Holdings Corp. Combine Operations in $1.1 Billion Deal
    FDA Grants De Novo Clearance to Medtronic’s GI Genius Model
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Bristol Myers Squibb Expands at Cambridge Crossing
    Amgen Completes Five Prime Acquisition
    Sartorius Expands in the UK
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Former L’Oréal Exec Joins Glossier
    Lancôme Reveals New Global Sustainability Program
    First-Ever Skincare Line Focuses on Iron To Prevent Aging
    Happi

    Latest Breaking News From Happi

    Fragrance Creators Association Celebrates P&G Executive
    Evonik Highlights Solutions for Malodor Reduction
    P&G Emphasizes Small Actions at Home To Be More Sustainable
    Ink World

    Latest Breaking News From Ink World

    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    SE-DA Invests in Kornit Presto S
    Acrylic Resins Market Worth $21.9 Billion by 2025: MarketsandMarkets
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    TLMI reveals Eugene Singer Award winners at Virtual Spring Summit
    Monadnock Paper Mills joins SGP
    ACTEGA helps converter reach sustainability goals
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Albaad to Add Natural-Based Line in Israel
    First Quality to Discontinue Tampon Operations
    Jessup Installs New Era Coating and Laminating Line
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    BioMagnetic Sciences Names President and CEO
    Mainstay Medical Launches ReActiv8 in Australia
    Biogennix Rolls Out Agilon Strip Bone Graft
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Virtual ASMC 2021 Spotlights Advanced Semiconductor Manufacturing Excellence
    LG Display Cuts Down CO2-eq Emissions by 3 Million Tons in 2020
    European Commission's Innovation Radar Acknowledges 3 ARMOR Innovations

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login